4.7 Article

Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease

期刊

NEUROLOGY
卷 83, 期 21, 页码 1906-1913

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000001012

关键词

-

资金

  1. Belgian Science Policy Office Interuniversity Attraction Poles (IAP)
  2. European Initiative on Centers of Excellence in Neurodegeneration (CoEN)
  3. Flemish Government initiated Methusalem Excellence Program
  4. Alzheimer Research Foundation (SAO/FRA)
  5. Queen Elisabeth Medical Foundation (QEMF)
  6. Research Foundation Flanders (FWO)
  7. Agency for Innovation by Science and Technology Flanders (IWT)
  8. University of Antwerp Research Fund, Belgium
  9. MetLife Foundation for Medical Research Award
  10. France-Parkinson Association
  11. French program Investissements d'avenir [ANR-10-IAIHU-06]
  12. USA-Florida: Mayo Clinic Florida is a Morris K. Udall Center of Excellence in PD Research NIH/NINDS [P50 NS072187]
  13. NINDS [R01 NS078086]
  14. Michael J. Fox Foundation
  15. Mayo Clinic Center for Regenerative Medicine
  16. Hermann and Lilly Schilling Foundation
  17. Forschungszentrum fur Umwelt und Gesundheit
  18. German Federal Ministry of Education, Science, Research, and Technology
  19. State of Bavaria
  20. German National Genome Network [01GS08134]
  21. German National Genome Network (German Ministry for Education and Research)
  22. German Federal Ministry of Education and Research [NGFN 01GR0468]
  23. ERA-NET NEURON [01EW0908]
  24. Helmholtz Alliance Mental Health in an Ageing Society [HA-215]
  25. Initiative and Networking Fund of the Helmholtz Association
  26. Research Committee of University of Thessaly [2845]
  27. Swedish Parkinson Foundation (Parkinsonfonden)
  28. Swedish National Health Services (ALF-YF)
  29. NIH [R01NS069936, R01NS058850, R01ES10751]
  30. Korea Healthcare technology R & D Project, Ministry of Health & Welfare, Republic of Korea [A092042]
  31. Asan Institute for Life Sciences [2010-0416]

向作者/读者索取更多资源

Objectives: The objective of this study is to clarify the role of (G(4)C(2))(n) expansions in the etiology of Parkinson disease (PD) in the worldwide multicenter Genetic Epidemiology of Parkinson's Disease (GEO-PD) cohort. Methods: C9orf72 (G(4)C(2))(n) repeats were assessed in a GEO-PD cohort of 7,494 patients diagnosed with PD and 5,886 neurologically healthy control individuals ascertained in Europe, Asia, North America, and Australia. Results: A pathogenic (G(4)C(2))(n). 60 expansion was detected in only 4 patients with PD (4/7,232; 0.055%), all with a positive family history of neurodegenerative dementia, amyotrophic lateral sclerosis, or atypical parkinsonism, while no carriers were detected with typical sporadic or familial PD. Meta-analysis revealed a small increase in risk of PD with an increasing number of (G(4)C(2)) n repeats; however, we could not detect a robust association between the C9orf72 (G(4)C(2))(n) repeat and PD, and the population attributable risk was low. Conclusions: Together, these findings indicate that expansions in C9orf72 do not have a major role in the pathogenesis of PD. Testing for C9orf72 repeat expansions should only be considered in patients with PD who have overt symptoms of frontotemporal lobar degeneration/amyotrophic lateral sclerosis or apparent family history of neurodegenerative dementia or motor neuron disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据